Cargando…
Circulating S100A8/A9 is potentially a biomarker that could reflect the severity of experimental colitis in rats
AIMS: The clinical significance of circulating S100A8/A9 (calprotectin) in patients with ulcerative colitis (UC) is poorly understood. We examined whether serum S100A8/A9 is a good biomarker for UC, and whether the serum level is a useful index for the severity of the disease. MAIN METHODS: Experime...
Autores principales: | Okada, Kohki, Itoh, Hiroshi, Ikemoto, Masaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052069/ https://www.ncbi.nlm.nih.gov/pubmed/32140589 http://dx.doi.org/10.1016/j.heliyon.2020.e03470 |
Ejemplares similares
-
A New Hybrid Protein Is a Novel Regulator for Experimental Colitis in Rats
por: Okada, Kohki, et al.
Publicado: (2021) -
Carbonic Anhydrase III Has Potential as a Biomarker for Experimental Colitis and Functions as an Immune Regulator by Inhibiting Inflammatory Cytokine Secretion
por: Okada, Kohki, et al.
Publicado: (2022) -
Serum complement C3 and α(2)-macroglobulin are potentially useful biomarkers for inflammatory bowel disease patients
por: Okada, Kohki, et al.
Publicado: (2021) -
S100A8 and S100A9 in experimental osteoarthritis
por: Zreiqat, Hala, et al.
Publicado: (2010) -
Nicotine Exerts a Stronger Immunosuppressive Effect Than Its Structural Analogs and Regulates Experimental Colitis in Rats
por: Okada, Kohki, et al.
Publicado: (2023)